Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #2024169

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
5,078,000 USD
138,924,000 USD
5,050,000 USD
Adjustments for decrease (increase) in trade and other receivables
9,750,000 USD
7,734,000 USD
617,000 USD
Adjustments for decrease (increase) in other current assets
2,834,000 USD
862,000 USD
5,350,000 USD
Adjustments for gains (losses) on change in fair value of derivatives
USD
8,163,000 USD
800,000 USD
Adjustments for gain (loss) on disposals, property, plant and equipment
318,000 USD
138,000 USD
53,000 USD
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
61,787,000 USD
27,251,000 USD
USD
Cash flows from (used in) investing activities [abstract]
Purchase of interests in associates
USD
19,961,000 USD
USD
Purchase of financial instruments, classified as investing activities
178,860,000 USD
248,733,000 USD
USD
Proceeds from sales or maturity of financial instruments, classified as investing activities
244,556,000 USD
50,000,000 USD
USD
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
1,153,000 USD
332,000 USD
352,000 USD
Proceeds from issue of preference shares
USD
USD
37,610,000 USD
Proceeds from issue of bonds, notes and debentures
USD
393,000 USD
2,215,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.